MapLight Therapeutics, Inc.
No trades
No trades
Fundamentals and stats
Operating, investing, and financing activities
Free cash flow for Q2 26 is −44.89 M USD. For 2025, it was −138.61 M USD and operating cash flow was −138.14 M USD.
2022
2023
2024
2025
Cash flow from operating activities
Cash flow from investing activities
Cash flow from financing activities
MetricsCurrency: USD
2022
2023
2024
2025
TTM